Clinical Trials Browser

Phase 3 × Pluvicto × 90 days × Clear all

NCT04720157 2026-03-11

PSMAddition

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT06959433 2026-02-27

Lu-177 PSMA Treatment in Cell Renal Carcinoma

Phase 3 Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04689828 2026-02-20

PSMAfore

Phase 3 Active not recruiting

469 enrolled 11 charts 1 FDA

Prostatic Neoplasms